Robert Taub
Manager
foamix pharmaceuticals
NeuroDerm
Israel
Biography
Mr. Taub has served as a member of the Board of Directors since July 2007 and chairman of its board of directors since November 2013. He founded and filled the role of CEO and a member of the board of directors of Omrix Biopharmaceuticals Inc., a biopharmaceutical company that developed, manufactured, and marketed biological products for the biosurgical and immunotherapy markets. The company was acquired by Johnson & Johnson in 2008. Mr. Taub is Chairman of Nyxoah S.A., which develops implants to treat sleep apnea, and director of LifeBond, Ltd., a company that develops surgical sealants.
Research Interest
Pharmaceutical science
